CAS: 67700-30-5; 2-(3-Phenylbenzofuran-7-yl)Propanoic Acid

该化合物是一种主要用于其止痛和抗炎特性的非类固醇抗炎药物(NSAID),被归类为一种丙基酸衍生物,在结构上与ibuprofen有关.Furaprofen通过抑制环氧基酶(COX)酶而开展的工作,这种酶酶酶在混合丙烷,介质性炎和疼痛的化合物方面起着关键作用.这种抑制导致炎症,疼痛和发烧的减少.该物质通常通过口服施用,并因其在治疗关节炎和其他炎症方面的有效性而著称.Furaprofen的毒性特征相对较低,但与其他非典药物一样,它可能会对某些病人造成胃肠侧效应,心血管风险和肾损伤.其药理学影响包括吸收,传播,新陈代谢和排泄,并导致半衰期,从而可以有效施药.与任何药物的相互作用,对于在药物下减少其他药物的不良作用至关重要.

结构式图片

合成工艺路线路线简述

    海关参考信息

    专利信息


    专利号:US-2013035307-A1
    优先权日:2010-01-26
    标 题:Methods for treating or preventing the spread of cancer using semi-synthetic glycosaminoglycosan ethers
    发明人:PRESTWICH GLENN D; KENNEDY THOMAS P
    权利人:UNIV UTAH RES FOUND; PRESTWICH GLENN D; KENNEDY THOMAS P
    摘要:Described herein are methods for the treatment and prevention of tumor metastasis using alkylated and fluoroalkylated semi-synthetic glycosaminoglycan ethers (“SAGEsâ€?). The synthesis of sulfated alkylated and fluoroalkylated SAGEs is also described.

    专利号:WO-2023096715-A9
    优先权日:2021-10-22
    标 题:Immunomodulatory glycosphingolipids and methods of use thereof
    发明人:KASPER DENNIS; OH SUNGWHAN
    权利人:HARVARD COLLEGE
    摘要:Provided herein are a subset of alpha-galactosylceramide (alpha-GC) compounds having improved immunomodulatory activity, particularly with respect to NKT cell number and activity. Also provided herein are methods of use of such compounds, including in the modulation of NKT cells and/or activity in vivo. Further provided are combinatorial synthesis methods for generating alpha-GC compounds of specifically defined structure and thereby generating pure preparations thereof.

    专利号:US-2022125838-A1
    优先权日:2019-02-11
    标题 :Immunomodulatory glycosphingolipids and methods of use thereof
    发明人:OH SUNGWHAN; KASPER DENNIS L; SONG HEEBUM; PARK SEUNG BUM
    权利人:HARVARD COLLEGE; SEOUL NAT UNIV R&DB FOUNDATION
    摘要:Provided herein are a subset of alpha-galactosylceramide (alpha-GC) compounds having improved immunomodulatory activity, particularly with respect to NKT cell number and activity. Also provided herein are methods of use of such compounds, including in the modulation of NKT cells and/or activity in vivo. Further provided are combinatorial synthesis methods for generating alpha-GC compounds of specifically defined structure and thereby generating pure preparations thereof.

    专利号:US-9907753-B2
    优先权日:2010-03-19
    标 题 :Lipid vesicle compositions and methods of use
    发明人:IRVINE DARRELL J; MOON JAEHYUN
    权利人:MASSACHUSETTS INST TECHNOLOGY
    摘要:The invention provides delivery systems comprised of stabilized multilamellar vesicles, as well as compositions, methods of synthesis, and methods of use thereof. The stabilized multilamellar vesicles may comprise prophylactic, therapeutic and/or diagnostic agents.

    专利号:US-2023407258-A1
    优先权日:2019-09-16
    标 题:Treatment of disc degenerative disease and stimulation of proteoglycan synthesis by fibroblast conditioned media and formulations thereof

    专利号:WO-2021055448-A1
    优先权日:2019-09-16
    标题:Treatment of disc degenerative disease and stimulation of proteoglycan synthesis by fibroblast conditioned media and formulations thereof

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    主要参考文献


    1: Carlucci G, Mazzeo P. Simultaneous determination of furprofen and rufloxacin in human plasma by high-performance liquid chromatography. J Chromatogr Sci. 1996 Apr;34(4):182-4. doi: 10.1016/j.chroma.2014.09.034. Epub 2014 Sep 22.

    合成参考文献


    摘要:Archives Internationales de Pharmacodynamie et de Therapie., 214(240), 1975 []
    摘要:Journal of Clinical Pharmacology., 16(473), 1976 []
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知